C7-Fluoro Substituted Tetracycline Compounds

Patent No. EP3000805 (titled "C7-Fluoro Substituted Tetracycline Compounds") was filed by Tetraphase Pharmaceuticals on Aug 7, 2009. The application was issued on Oct 18, 2017.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Company	Opposition Date	Representative
SANDOZ	Jul 18, 2018	LAMPING

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

Date
Description

Get instant alerts for new documents

Jul 9, 2021
Communication to the parties concerning the termination of the opposition proceedings (opponent)
Jul 9, 2021
Communication to the parties concerning the termination of the opposition proceedings (proprietor)
Jul 6, 2021
Termination of the opposition proceedings with revocation of patent
Mar 24, 2021
Advice of delivery
Mar 24, 2021
Decision revoking the European Patent (patent proprietor)
Mar 24, 2021
Decision revoking the European patent (opponent)
Mar 24, 2021
Transmittal of decision / summons - opposition
Mar 24, 2021
Transmittal of decision / summons - opposition
Dec 4, 2020
Communication concerning surcharge and failure to observe time limit
Jul 14, 2020
Communication of bibliographic data
Jul 14, 2020
Communication to opponent concerning maintenance
Jul 14, 2020
Communication with request to file translations
Jul 3, 2020
Maintenance of the patent with the documents specified in the final decision
Jul 3, 2020
Maintenance of the patent with the documents specified in the final decision
Mar 9, 2020
Advice of delivery
Feb 27, 2020
Advice of delivery
Feb 27, 2020
Communication about missing advice of delivery
Feb 27, 2020
Cover sheet for fax transmission
Feb 6, 2020
Advice of delivery
Jan 22, 2020
Acknowledgement of a document
Jan 22, 2020
Acknowledgement of a document
Jan 22, 2020
Decision of the Opposition Division and instruction
Jan 22, 2020
Druckexemplar in opposition procedure
Jan 22, 2020
Grounds for the decision (Annex) - opposition
Jan 22, 2020
Interlocutory decision in opposition proceedings
Jan 22, 2020
Internal form - Opposition/addressees
Jan 22, 2020
Means of redress
Jan 2, 2020
Brief communication - Opposition proceedings
Dec 18, 2019
(Electronic) Receipt
Dec 18, 2019
Letter accompanying subsequently filed items
Dec 18, 2019
Letter regarding the opposition procedure (no time limit)
Dec 5, 2019
Brief communication - Opposition proceedings
Nov 26, 2019
(Electronic) Receipt
Nov 26, 2019
Amended description with annotations
Nov 26, 2019
Description
Nov 26, 2019
Letter accompanying subsequently filed items
Nov 26, 2019
Reply to an examination report in opposition proceedings
Nov 14, 2019
Annex to the communication - opposition
Nov 14, 2019
Communication inviting the parties to file observations
Nov 14, 2019
Internal form - Opposition/addressees
Aug 7, 2019
Brief communication - Opposition proceedings
Aug 1, 2019
(Electronic) Receipt
Aug 1, 2019
Letter accompanying subsequently filed items
Aug 1, 2019
Reply to an examination report in opposition proceedings
Apr 2, 2019
Annex to the communication - opposition
Apr 2, 2019
Communication inviting the parties to file observations
Apr 2, 2019
Communication inviting the parties to file observations
Apr 2, 2019
Internal form - Opposition/addressees
Dec 14, 2018
Submission concerning representation
Dec 4, 2018
Brief communication - Opposition proceedings
Nov 27, 2018
(Electronic) Receipt
Nov 27, 2018
Amended claims with annotations
Nov 27, 2018
Amended claims with annotations
Nov 27, 2018
Amended claims with annotations
Nov 27, 2018
Amended claims with annotations
Nov 27, 2018
Amended description with annotations
Nov 27, 2018
Claims
Nov 27, 2018
Claims
Nov 27, 2018
Claims
Nov 27, 2018
Claims
Nov 27, 2018
Description
Nov 27, 2018
Letter accompanying subsequently filed items
Nov 27, 2018
Letter regarding the opposition procedure (no time limit)
Nov 27, 2018
Reply of the patent proprietor to the notice(s) of opposition
Aug 1, 2018
Communication of a notice of opposition and request to file observations
Aug 1, 2018
Notice of further oppositions to opponent(s)
Jul 30, 2018
Communication of a notice of opposition - first information to patent proprietor
Jul 18, 2018
Letter concerning fees and payments
Jul 18, 2018
Non-patent literature cited during the opposition procedure
Jul 18, 2018
Non-patent literature cited during the opposition procedure
Jul 18, 2018
Non-patent literature cited during the opposition procedure
Jul 18, 2018
Non-patent literature cited during the opposition procedure
Jul 18, 2018
Non-patent literature cited during the opposition procedure
Jul 18, 2018
Non-patent literature cited during the opposition procedure
Jul 18, 2018
Non-patent literature cited during the opposition procedure
Jul 18, 2018
Non-patent literature cited during the opposition procedure
Jul 18, 2018
Notice of opposition
Jul 18, 2018
Notice of opposition
Jul 18, 2018
Patent document cited during the opposition procedure
Oct 26, 2017
Transmission of the certificate for a European patent pursuant to Rule 74 EPC
Sep 21, 2017
Decision to grant a European patent
Sep 5, 2017
(Electronic) Receipt
Sep 5, 2017
Filing of the translations of the claims
Sep 5, 2017
French translation of claims
Sep 5, 2017
German translation of the claims
Sep 5, 2017
Letter accompanying subsequently filed items
Apr 26, 2017
Bibliographic data of the European patent application
Apr 26, 2017
Communication about intention to grant a European patent
Apr 26, 2017
Intention to grant (signatures)
Apr 26, 2017
Text intended for grant (clean copy)
Apr 26, 2017
Text intended for grant (version for approval)
Apr 5, 2017
Examination started
Sep 15, 2016
(Electronic) Receipt
Sep 15, 2016
Amended description filed after receipt of (European) search report
Sep 15, 2016
Amended description with annotations
Sep 15, 2016
Amendments received before examination
Sep 15, 2016
Letter accompanying subsequently filed items
Apr 4, 2016
Invitation to confirm maintenance of the application and to correct deficiencies in the Written Opinion/amend application
Mar 2, 2016
Notification of forthcoming publication
Feb 10, 2016
Refund of fees
Feb 8, 2016
Communication regarding the transmission of the European search report
Feb 8, 2016
European search opinion
Feb 8, 2016
European search report
Feb 8, 2016
Information on Search Strategy
Jan 20, 2016
Search started
Dec 2, 2015
Refund of fees
Nov 26, 2015
CDS Clean up - amended data concerning the representative of the applicant (Association)
Nov 17, 2015
(Electronic) Receipt
Nov 17, 2015
Amended claims with annotations
Nov 17, 2015
Claims
Nov 17, 2015
Letter accompanying subsequently filed items
Nov 17, 2015
Matter concerning the application
Oct 5, 2015
Communication to designated inventor
Oct 5, 2015
Communication to designated inventor
Oct 5, 2015
Communication to designated inventor
Oct 5, 2015
Communication to designated inventor
Oct 5, 2015
Communication to designated inventor
Oct 5, 2015
Communication to designated inventor
Sep 25, 2015
Invitation to file claims
Aug 11, 2015
Abstract
Aug 11, 2015
Acknowledgement of receipt of electronic submission of the request for grant of a European patent
Aug 11, 2015
Description
Aug 11, 2015
Designation of inventor
Aug 11, 2015
Matter concerning the application
Aug 11, 2015
Request for grant of a European patent
Mar 3, 2010
Priority document (electronically transmitted)

EP3000805

TETRAPHASE PHARMACEUTICALS

Application Number: EP15180611A
Filing Date: Aug 7, 2009
Status: Revoked; Jul 9, 2021
Publication Date: Oct 18, 2017
External Links: Slate, Register , Google Patents

IP Verse

C7-Fluoro Substituted Tetracycline Compounds

Patent Summary

Patent Family

Patent Oppositions

Dossier Documents

EP3000805